MD20130098A2 - Test pentru determinarea lizil oxidazei-2 şi metode de utilizare a acestuia - Google Patents

Test pentru determinarea lizil oxidazei-2 şi metode de utilizare a acestuia

Info

Publication number
MD20130098A2
MD20130098A2 MDA20130098A MD20130098A MD20130098A2 MD 20130098 A2 MD20130098 A2 MD 20130098A2 MD A20130098 A MDA20130098 A MD A20130098A MD 20130098 A MD20130098 A MD 20130098A MD 20130098 A2 MD20130098 A2 MD 20130098A2
Authority
MD
Moldova
Prior art keywords
assay
lysyl oxidase
methods
loxl2
polypeptides
Prior art date
Application number
MDA20130098A
Other languages
English (en)
Russian (ru)
Inventor
Виктория СМИТ
Джоан И. Адамкевич
Сьюзен ЛИМАН
Джейсон ЧИЭНЬ
Сяомин Ли
Лисинь Шао
Джеффри БОРНШТАЙН
Original Assignee
Gilead Biologics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46208194&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MD20130098(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gilead Biologics, Inc. filed Critical Gilead Biologics, Inc.
Publication of MD20130098A2 publication Critical patent/MD20130098A2/ro

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Silicon Polymers (AREA)

Abstract

Prezenta invenţie se referă la un test pentru detectarea şi/sau cuantificarea polipeptidelor lizil oxidazei-2 circulante (LOXL2) la om. Analiza este utilă pentru aplicaţiile diagnostice şi prognostice, care sunt de asemenea prevăzute.
MDA20130098A 2011-06-01 2012-06-01 Test pentru determinarea lizil oxidazei-2 şi metode de utilizare a acestuia MD20130098A2 (ro)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161492210P 2011-06-01 2011-06-01
US201161550895P 2011-10-24 2011-10-24
US201161578813P 2011-12-21 2011-12-21
PCT/US2012/040585 WO2012167181A1 (en) 2011-06-01 2012-06-01 Lysyl oxidase-like 2 assay and methods of use thereof

Publications (1)

Publication Number Publication Date
MD20130098A2 true MD20130098A2 (ro) 2014-06-30

Family

ID=46208194

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20130098A MD20130098A2 (ro) 2011-06-01 2012-06-01 Test pentru determinarea lizil oxidazei-2 şi metode de utilizare a acestuia

Country Status (24)

Country Link
US (3) US20120309020A1 (ro)
EP (1) EP2714744A1 (ro)
JP (3) JP2014523521A (ro)
KR (1) KR20140048156A (ro)
CN (1) CN103946241A (ro)
AP (1) AP2013007285A0 (ro)
AR (1) AR086657A1 (ro)
AU (2) AU2012261883A1 (ro)
BR (1) BR112013030682A2 (ro)
CA (1) CA2837534A1 (ro)
CL (1) CL2013003445A1 (ro)
CO (1) CO6940375A2 (ro)
CR (1) CR20130657A (ro)
EA (1) EA201391627A1 (ro)
EC (1) ECSP13013092A (ro)
IL (1) IL229631A0 (ro)
MA (1) MA35212B1 (ro)
MD (1) MD20130098A2 (ro)
MX (1) MX2013013905A (ro)
PE (1) PE20141450A1 (ro)
TW (1) TW201319572A (ro)
UY (1) UY34115A (ro)
WO (1) WO2012167181A1 (ro)
ZA (1) ZA201308812B (ro)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030114410A1 (en) 2000-08-08 2003-06-19 Technion Research And Development Foundation Ltd. Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
ES2402334T3 (es) 2007-08-02 2013-04-30 Gilead Biologics, Inc Procedimientos y composiciones para el tratamiento y el diagnóstico de la fibrosis
US9107935B2 (en) 2009-01-06 2015-08-18 Gilead Biologics, Inc. Chemotherapeutic methods and compositions
AU2010284036B2 (en) 2009-08-21 2014-12-18 Gilead Biologics, Inc. Catalytic domains from lysyl oxidase and LOXL2
MX2012009088A (es) 2010-02-04 2012-12-05 Gilead Biologics Inc Anticuerpos que se enlazan a lisil oxidasa-tipo2 (loxl2) y metodos de uso para los mismos.
SG10201703240RA (en) * 2012-10-30 2017-06-29 Gilead Sciences Inc Therapeutic and diagnostic methods related to lysyl oxidase-like 2 (loxl2)
WO2015187499A1 (en) 2014-06-03 2015-12-10 Gilead Sciences, Inc. Use of an ask1 inhibitor for the treatment of liver disease, optionally in combination with a loxl2 inhibitor
US20150361182A1 (en) * 2014-06-11 2015-12-17 Gilead Sciences, Inc. Methods for treating cardiovascular diseases
MA41252A (fr) 2014-12-23 2017-10-31 Gilead Sciences Inc Formes solides d'un inhibiteur d'ask 1
WO2017152062A1 (en) 2016-03-04 2017-09-08 Gilead Sciences, Inc. Compositions and combinations of autotaxin inhibitors
CA3019003A1 (en) 2016-04-08 2017-10-12 Gilead Sciences, Inc. Compositions and methods for treating cancer, inflammatory diseases and autoimmune diseases
GB201704206D0 (en) * 2017-03-16 2017-05-03 Nordic Bioscience As Lysyl oxidase like-2 assay
WO2023091479A1 (en) * 2021-11-17 2023-05-25 AmMax Bio, Inc. Detection and treatment of idiopathic pulmonary fibrosis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6352862B1 (en) * 1989-02-17 2002-03-05 Unilever Patent Holdings B.V. Analytical test device for imuno assays and methods of using same
FI92882C (fi) * 1992-12-29 1995-01-10 Medix Biochemica Ab Oy Kertakäyttöinen testiliuska ja menetelmä sen valmistamiseksi
US20030114410A1 (en) * 2000-08-08 2003-06-19 Technion Research And Development Foundation Ltd. Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
ES2402334T3 (es) * 2007-08-02 2013-04-30 Gilead Biologics, Inc Procedimientos y composiciones para el tratamiento y el diagnóstico de la fibrosis
JP2010038735A (ja) * 2008-08-05 2010-02-18 Terumo Corp 腹膜機能の評価方法および腹膜機能評価用イムノクロマト試験紙
CA2771786A1 (en) * 2009-08-21 2011-02-24 Gilead Biologics, Inc. In vivo screening assays
MX2012009088A (es) * 2010-02-04 2012-12-05 Gilead Biologics Inc Anticuerpos que se enlazan a lisil oxidasa-tipo2 (loxl2) y metodos de uso para los mismos.
US9556882B2 (en) * 2011-05-10 2017-01-31 Borgwarner Inc. Turbocharger with variable turbine geometry

Also Published As

Publication number Publication date
CN103946241A (zh) 2014-07-23
US20170269085A1 (en) 2017-09-21
WO2012167181A1 (en) 2012-12-06
AP2013007285A0 (en) 2013-11-30
KR20140048156A (ko) 2014-04-23
JP2018049033A (ja) 2018-03-29
AU2012261883A1 (en) 2013-05-02
NZ618682A (en) 2016-04-29
CL2013003445A1 (es) 2014-07-25
AR086657A1 (es) 2014-01-15
JP2016164578A (ja) 2016-09-08
AU2016244254B2 (en) 2018-10-18
PE20141450A1 (es) 2014-11-06
AU2016244254A1 (en) 2016-11-03
TW201319572A (zh) 2013-05-16
MA35212B1 (fr) 2014-06-02
EP2714744A1 (en) 2014-04-09
CR20130657A (es) 2014-05-16
UY34115A (es) 2013-01-03
CO6940375A2 (es) 2014-05-09
US20140206017A1 (en) 2014-07-24
ZA201308812B (en) 2014-08-27
IL229631A0 (en) 2014-01-30
CA2837534A1 (en) 2012-12-06
EA201391627A1 (ru) 2014-08-29
MX2013013905A (es) 2014-05-14
US20120309020A1 (en) 2012-12-06
ECSP13013092A (es) 2014-08-29
BR112013030682A2 (pt) 2016-12-06
JP2014523521A (ja) 2014-09-11

Similar Documents

Publication Publication Date Title
MD20130098A2 (ro) Test pentru determinarea lizil oxidazei-2 şi metode de utilizare a acestuia
MX2011011942A (es) Metodos para el diagnostico de trastornos oncologicos usando intercambiadores epimetabolicos, moleculas intracelulares multidimensionales, o influyentes ambientales.
MX2015005448A (es) Metodos de terapia y diagnostico relacionados con lisil oxidasa-tipo 2 (loxl2).
EA201600085A1 (ru) Набор для обнаружения соевого события syht0h2
GB2498163A (en) High-throughput immune sequencing
UY34484A (es) Benzotienilo-pirrolotriazinas disustituidas y sus usos
GB2519906A (en) Methods and systems for detecting biological components
IN2015DN01300A (ro)
NZ606725A (en) Methods for predicting anti-cancer response
EP2576837A4 (en) CIRCULATING NUCLEIC ACID BIOMARKERS ASSOCIATED WITH PROSTATE CANCER
IN2014DN08831A (ro)
MY170983A (en) Biomarker assays for detecting or measuring inhibition of tor kinase activity
CR20150247A (es) Anticuerpos de antihemaglutinina y métodos de uso
WO2013039477A8 (en) Non-invasive methods of detecting target molecules
BR112015008621A2 (pt) Métodos e kit de diagnóstico e/ou prognóstico in vitro microconjunto de ácidos nucleicos.
PH12014502436A1 (en) In vitro method for the diagnosis and surveillance of cancer
MX358474B (es) Biomarcadores salivales específicos para detección de riesgo, diagnóstico temprano, pronóstico y vigilancia de las enfermedades de alzheimer y de parkinson.
WO2011143574A3 (en) Plasma biomarkers for diagnosis of alzheimer's disease
MX2015001961A (es) Metodos y sistemas para ensayos.
GB201206977D0 (en) An enzyme detection device
NZ592994A (en) Diagnostic test for Streptococcus equi comprising assessing the presence or absence of the S. equi eqbE gene
SG168423A1 (en) Influenza detection method and kit therefor
WO2015091902A3 (en) Determination of platelet-mirnas in alzheimer's disease
WO2014143931A3 (en) Multi-biomarker biosensor
UY34831A (es) Glucosiltransferasa de esteviol y genes que codifican la misma

Legal Events

Date Code Title Description
FA9A Abandonment or withdrawal of application (patent for invention)